These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37178120)

  • 1. Fortuitous somatic mutations during antibody evolution endow broad neutralization against SARS-CoV-2 Omicron variants.
    Wu J; Chen Z; Gao Y; Wang Z; Wang J; Chiang BY; Zhou Y; Han Y; Zhan W; Xie M; Jiang W; Zhang X; Hao A; Xia A; He J; Xue S; Mayer CT; Wu F; Wang B; Zhang L; Sun L; Wang Q
    Cell Rep; 2023 May; 42(5):112503. PubMed ID: 37178120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fortuitous Somatic Mutations during Antibody Evolution Endow Broad Neutralization against SARS-CoV-2 Omicron Variants.
    Wu J; Chen Z; Gao Y; Wang Z; Wang J; Chiang BY; Zhou Y; Han Y; Zhan W; Xie M; Jiang W; Zhang X; Hao A; Xia A; He J; Xue S; Mayer CT; Wu F; Wang B; Zhang L; Sun L; Wang Q
    bioRxiv; 2022 Dec; ():. PubMed ID: 36561175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of cross-reactive monoclonal antibodies against SARS-CoV-1 and SARS-CoV-2: Implication for rational design and development of pan-sarbecovirus vaccines and neutralizing antibodies.
    Li S; Wu J; Jiang W; He H; Zhou Y; Wu W; Gao Y; Xie M; Xia A; He J; Zhang Q; Han Y; Wang N; Zhu G; Wang Q; Zhang Z; Mayer CT; Wang K; Wang X; Wang J; Chen Z; Jiang S; Sun L; Xia R; Wang Q
    J Med Virol; 2023 Feb; 95(2):e28440. PubMed ID: 36573441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery and intranasal administration of a SARS-CoV-2 broadly acting neutralizing antibody with activity against multiple Omicron subvariants.
    Duty JA; Kraus T; Zhou H; Zhang Y; Shaabani N; Yildiz S; Du N; Singh A; Miorin L; Li D; Stegman K; Ophir S; Cao X; Atanasoff K; Lim R; Mena I; Bouvier NM; Kowdle S; Carreño JM; Rivero-Nava L; Raskin A; Moreno E; Johnson S; Rathnasinghe R; Pai CI; Kehrer T; Cabral EP; Jangra S; Healy L; Singh G; Warang P; Simon V; Sordillo EM; van Bakel H; Liu Y; Sun W; Kerwin L; Teijaro J; Schotsaert M; Krammer F; Bresson D; García-Sastre A; Fu Y; Lee B; Powers C; Moran T; Ji H; Tortorella D; Allen R
    Med; 2022 Oct; 3(10):705-721.e11. PubMed ID: 36044897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent monoclonal antibodies neutralize Omicron sublineages and other SARS-CoV-2 variants.
    Chen Z; Zhang P; Matsuoka Y; Tsybovsky Y; West K; Santos C; Boyd LF; Nguyen H; Pomerenke A; Stephens T; Olia AS; Zhang B; De Giorgi V; Holbrook MR; Gross R; Postnikova E; Garza NL; Johnson RF; Margulies DH; Kwong PD; Alter HJ; Buchholz UJ; Lusso P; Farci P
    Cell Rep; 2022 Nov; 41(5):111528. PubMed ID: 36302375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Broadly neutralizing human antibodies against Omicron subvariants of SARS-CoV-2.
    Chiang HL; Liang KH; Lu RM; Kuo TW; Lin YL; Wu HC
    J Biomed Sci; 2023 Jul; 30(1):59. PubMed ID: 37525188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 Omicron sublineages exhibit distinct antibody escape patterns.
    Gruell H; Vanshylla K; Korenkov M; Tober-Lau P; Zehner M; Münn F; Janicki H; Augustin M; Schommers P; Sander LE; Kurth F; Kreer C; Klein F
    Cell Host Microbe; 2022 Sep; 30(9):1231-1241.e6. PubMed ID: 35921836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Broadly neutralizing antibodies against sarbecoviruses generated by immunization of macaques with an AS03-adjuvanted COVID-19 vaccine.
    Feng Y; Yuan M; Powers JM; Hu M; Munt JE; Arunachalam PS; Leist SR; Bellusci L; Kim J; Sprouse KR; Adams LE; Sundaramurthy S; Zhu X; Shirreff LM; Mallory ML; Scobey TD; Moreno A; O'Hagan DT; Kleanthous H; Villinger FJ; Veesler D; King NP; Suthar MS; Khurana S; Baric RS; Wilson IA; Pulendran B
    Sci Transl Med; 2023 May; 15(695):eadg7404. PubMed ID: 37163615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis of broad SARS-CoV-2 cross-neutralization by affinity-matured public antibodies.
    Sheward DJ; Pushparaj P; Das H; Greaney AJ; Kim C; Kim S; Hanke L; Hyllner E; Dyrdak R; Lee J; Dopico XC; Dosenovic P; Peacock TP; McInerney GM; Albert J; Corcoran M; Bloom JD; Murrell B; Karlsson Hedestam GB; Hällberg BM
    Cell Rep Med; 2024 Jun; 5(6):101577. PubMed ID: 38761799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent Omicron-neutralizing antibodies isolated from a patient vaccinated 6 months before Omicron emergence.
    Hastie KM; Yu X; Ana-Sosa-Batiz F; Zyla DS; Harkins SS; Hariharan C; Wasserman H; Zandonatti MA; Miller R; Maule E; Kim K; Valentine KM; Shresta S; Saphire EO
    Cell Rep; 2023 May; 42(5):112421. PubMed ID: 37083327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Broad strategies for neutralizing SARS-CoV-2 and other human coronaviruses with monoclonal antibodies.
    Ling Z; Yi C; Sun X; Yang Z; Sun B
    Sci China Life Sci; 2023 Apr; 66(4):658-678. PubMed ID: 36443513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omicron BQ.1.1 and XBB.1 unprecedentedly escape broadly neutralizing antibodies elicited by prototype vaccination.
    Ju B; Fan Q; Liu C; Shen S; Wang M; Guo H; Zhou B; Ge X; Zhang Z
    Cell Rep; 2023 Jun; 42(6):112532. PubMed ID: 37219999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-Neutralization of Emerging SARS-CoV-2 Variants of Concern by Antibodies Targeting Distinct Epitopes on Spike.
    Changrob S; Fu Y; Guthmiller JJ; Halfmann PJ; Li L; Stamper CT; Dugan HL; Accola M; Rehrauer W; Zheng NY; Huang M; Wang J; Erickson SA; Utset HA; Graves HM; Amanat F; Sather DN; Krammer F; Kawaoka Y; Wilson PC
    mBio; 2021 Dec; 12(6):e0297521. PubMed ID: 34781736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection.
    Cao Y; Yisimayi A; Jian F; Song W; Xiao T; Wang L; Du S; Wang J; Li Q; Chen X; Yu Y; Wang P; Zhang Z; Liu P; An R; Hao X; Wang Y; Wang J; Feng R; Sun H; Zhao L; Zhang W; Zhao D; Zheng J; Yu L; Li C; Zhang N; Wang R; Niu X; Yang S; Song X; Chai Y; Hu Y; Shi Y; Zheng L; Li Z; Gu Q; Shao F; Huang W; Jin R; Shen Z; Wang Y; Wang X; Xiao J; Xie XS
    Nature; 2022 Aug; 608(7923):593-602. PubMed ID: 35714668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A fourth dose of Omicron RBD vaccine enhances broad neutralization against SARS-CoV-2 variants including BA.1 and BA.2 in vaccinated mice.
    Zhou B; Song S; Guo H; Zhou X; Fan Q; Liu W; Cheng L; Ge X; Ju B; Zhang Z
    J Med Virol; 2022 Aug; 94(8):3992-3997. PubMed ID: 35474319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nasal delivery of broadly neutralizing antibodies protects mice from lethal challenge with SARS-CoV-2 delta and omicron variants.
    Lu J; Yin Q; Pei R; Zhang Q; Qu Y; Pan Y; Sun L; Gao D; Liang C; Yang J; Wu W; Li J; Cui Z; Wang Z; Li X; Li D; Wang S; Duan K; Guan W; Liang M; Yang X
    Virol Sin; 2022 Apr; 37(2):238-247. PubMed ID: 35527227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis of a two-antibody cocktail exhibiting highly potent and broadly neutralizing activities against SARS-CoV-2 variants including diverse Omicron sublineages.
    Li X; Pan Y; Yin Q; Wang Z; Shan S; Zhang L; Yu J; Qu Y; Sun L; Gui F; Lu J; Jing Z; Wu W; Huang T; Shi X; Li J; Li X; Li D; Wang S; Yang M; Zhang L; Duan K; Liang M; Yang X; Wang X
    Cell Discov; 2022 Sep; 8(1):87. PubMed ID: 36075908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatic hypermutation introduces bystander mutations that prepare SARS-CoV-2 antibodies for emerging variants.
    Korenkov M; Zehner M; Cohen-Dvashi H; Borenstein-Katz A; Kottege L; Janicki H; Vanshylla K; Weber T; Gruell H; Koch M; Diskin R; Kreer C; Klein F
    Immunity; 2023 Dec; 56(12):2803-2815.e6. PubMed ID: 38035879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three SARS-CoV-2 antibodies provide broad and synergistic neutralization against variants of concern, including Omicron.
    Wang S; Sun H; Zhang Y; Yuan L; Wang Y; Zhang T; Wang S; Zhang J; Yu H; Xiong H; Tang Z; Liu L; Huang Y; Chen X; Li T; Ying D; Liu C; Chen Z; Yuan Q; Zhang J; Cheng T; Li S; Guan Y; Zheng Q; Zheng Z; Xia N
    Cell Rep; 2022 May; 39(8):110862. PubMed ID: 35594869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural Study of SARS-CoV-2 Antibodies Identifies a Broad-Spectrum Antibody That Neutralizes the Omicron Variant by Disassembling the Spike Trimer.
    Zhan W; Tian X; Zhang X; Xing S; Song W; Liu Q; Hao A; Hu Y; Zhang M; Ying T; Chen Z; Lan F; Sun L
    J Virol; 2022 Aug; 96(16):e0048022. PubMed ID: 35924918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.